Winter 2012 Newsletter

Shapiro & Cho

From the Education Co-Directors

We're very proud of the progress YCCI has made in its first five years. 

We've attracted and trained an impressive group of Scholars who have great potential for successful careers in clinical and translational research.

CTSA Mentoring Trial Sites_map

Education Program Issue

As YCCI moves into the next five years of its Clinical and Translational Science Award (CTSA), we have a good opportunity to highlight one of our foundational programs: Education and Training.


2011 YCCI Junior Faculty Scholars

The newest round of Scholars is an accomplished group of investigators who are pursuing clinical and translational research projects aimed at some of the most challenging areas found in medicine today.

Mathieu Lemaire

Profile: Investigative Medicine Program (IMP)

Mathieu Lemaire, MSc, MDCM, a trainee in Yale's innovative Investigative Medicine Program, is conducting translational research in genomics to explore the underlying causes of renal disease.

Sadeghpour and Girardi_162x100

Profile: TL1 Training Program

Mona Sadeghpour, MD '12, a TL1 trainee, is investigating the role of Langerhans cells in UV-induced skin cancers during her fifth year of medical school.

Chris Pittenger

Workshop Lays Groundwork for International Collaboration

Scientific advances in neuroscience and genetics may be on the verge of producing fundamental transformations in psychiatry. Combined with a shortage of psychiatry trainees, these changes amount to a turning point for the field.


Expanded Event for All Scholars

On March 9, YCCI will be hosting an event open to all trainees in the Schools of Medicine, Nursing and Public Health that offers the opportunity for all Yale Scholars to learn from their colleagues.


YCCI RWJ Community Research Scholars

Yale is one of four sites in the country to provide research training through the Robert Wood Johnson (RWJ) Foundation Clinical Scholars Program, a two-year fellowship program that seeks to develop health leaders and influence the quality of health care.


An appropriations bill for FY 2012 that was signed into law in December includes funding for the NIH as well as specific language creating the National Center for Advancing Translational Sciences (NCATS). The CTSA program is now part of NCATS along with other programs slated for the new center. NCATS has a critical mission — to speed the discovery of next-generation methods and technologies to enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. The CTSAs will be a vital part of that mission.

As a reminder, the CTSA must be cited in your resulting publications, and the new citation is:

This publication was made possible by CTSA Grant Number UL1 RR024139 or KL2 RR024138 or TL1 RR024137 (as appropriate) from the National Center for Research Resources (NCRR) and the National Center for Advancing Translational Science (NCATS), components of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.

Research-in-Progress Presentations

These bimonthly meetings feature presentations from YCCI and IMP Scholars as well as trainees from the Medical Research Scholars Program (MRSP).

We encourage all faculty and staff to attend. All meetings take place at noon; lunch is provided.

Please click here to find the list of locations, presenters, and projects.